Biotechnology
Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still fell short
Eli Lilly’s blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro posted weaker-than-expected sales for the third quarter, even as supply of both medicines have largely recovered from widespread shortages in the U.S. The reason, according to the company, is not an issue of demand or supply. Eli Lilly instead blamed disappointing sales on drug […]
Read MoreEli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
Lilly Biotechnology Center is shown in San Diego, California, U.S. March 1, 2023. Mike Blake | Reuters Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro, and slashed its full-year adjusted profit guidance. […]
Read MoreBiogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer’s drug, Leqembi, and other new products gain traction. […]
Read MorePfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company’s Covid vaccine and antiviral pill Paxlovid helped boost sales. The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to $2.95, up […]
Read MoreCDC says 75 people affected in E. coli outbreak linked to McDonald’s Quarter Pounders
A quarter pounder with cheese, fries, and a drink arranged at a McDonald’s restaurant in El Sobrante, California, US, on Wednesday, Oct. 23, 2024. David Paul Morris | Bloomberg | Getty Images A deadly E. coli outbreak linked to McDonald‘s Quarter Pounders has led to 75 cases in 13 states, the Centers for Disease Control […]
Read MoreNovo Nordisk’s diabetes drug Ozempic may reduce the risk of Alzheimer’s disease, study says
Steve Christo – Corbis | Corbis News | Getty Images Novo Nordisk‘s blockbuster diabetes drug Ozempic may reduce the risk of developing Alzheimer’s disease, suggesting its potential to delay or prevent the memory-robbing condition, according to a study released Thursday. Semaglutide, the active ingredient in Ozempic, was associated with a 40% to 70% lower risk […]
Read MoreNovo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its popular weight loss injection Wegovy and diabetes treatment Ozempic, arguing that the medications are […]
Read MoreScotiabank says its 3 biotech ‘top pick’ stocks have more than 100% upside potential
Scotiabank has highlighted three biotechnology companies as its “top picks,” each with the potential to more than double in stock price over the next 12 months. The bank’s optimism for these companies and the broader biotechnology sector is partly based on anticipated changes in the macroeconomic environment. Greg Harrison, equity analyst at Scotiabank, said “macro […]
Read MoreDrug costs, abortion, Obamacare: How Trump and Harris could change U.S. health care
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and U.S. Vice President Kamala Harris speaks to mark the one-year anniversary of the Oct. 7 Hamas attacks on Israel, at the vice president’s residence at the U.S. Naval Observatory in Washington, Oct. 7, 2024. Getty […]
Read MoreMerck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read More